Hot Features
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessm... ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-care body composition analysis; and HF-Dex analysis for point-of-care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.001 | 16.6666666667 | 0.006 | 0.008 | 0.006 | 7998400 | 0.00679069 | DE |
| 4 | -0.001 | -12.5 | 0.008 | 0.009 | 0.006 | 7845938 | 0.00701266 | DE |
| 12 | -0.01 | -58.8235294118 | 0.017 | 0.018 | 0.006 | 5763847 | 0.00980989 | DE |
| 26 | -0.031 | -81.5789473684 | 0.038 | 0.0385 | 0.006 | 5887524 | 0.01623436 | DE |
| 52 | -0.023 | -76.6666666667 | 0.03 | 0.059 | 0.006 | 3834849 | 0.02245343 | DE |
| 156 | -0.143 | -95.3333333333 | 0.15 | 0.24 | 0.006 | 2649202 | 0.06570737 | DE |
| 260 | -0.118 | -94.4 | 0.125 | 0.24 | 0.006 | 2616904 | 0.0904595 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.